![](/img/cover-not-exists.png)
Corrigendum to: Subgroup analysis of Japanese patients in a Phase 3 study of atezolizumab in advanced triple-negative breast cancer (IMpassion130)
Iwata, Hiroji, Inoue, Kenichi, Kaneko, Koji, Ito, Yoshinori, Tsugawa, Koichiro, Hasegawa, Ayumi, Nakagawa, Shintaro, Kuratomi, Hiroyasu, Tamura, KenjiJournal:
Japanese Journal of Clinical Oncology
DOI:
10.1093/jjco/hyz208
Date:
January, 2020
File:
PDF, 108 KB
2020